【FINTEC 0150 交流专区】（前名 ASIABIO）

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31/10/2014

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/10/2014	31/10/2013	31/10/2014	31/10/2013
		$$'000	$$'000	$$'000	$$'000

1	Revenue	17,555	770	36,102	1,434
2	Profit/(loss) before tax	384	-1,914	-1,311	-976
3	Profit/(loss) for the period	384	-1,915	-1,311	-977
4	Profit/(loss) attributable to ordinary equity holders of the parent	394	-1,908	-1,278	-914
5	Basic earnings/(loss) per share (Subunit)	0.09	-0.48	-0.30	-0.23
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0764		0.0559

APULA

亞洲生物能源 重大宣佈今停牌
財經26 Jan 2015 23:00
http://www.chinapress.com.my/node/595186

（吉隆坡26日訊）亞洲生物能源（ASIABIO，0150，創業板貿服）將在明日（27日）上午9時至中午12時半暫停交易，以針對顯著企業活動進行宣布。

該公司向馬證交所報備，將在早盤暫停交易進行重大宣布。

亞洲生物能源將召開記者會，配合完成簽署顯著企業活動儀式。這項活動將對亞洲生物能源營業額和淨利作出正面公司，這是基于該公司將進行新領域。同時，公司管理層也會公布盈利前景和未來商業策略。

截至今日閉市，亞洲生物能源報19仙，升0.5仙，成交量3007萬9500股。

ype	Announcement
Subject	SUSPENSION OF SECURITIES
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD (“ASIABIO” OR “COMPANY”) - REQUEST FOR SUSPENSION OF TRADING
ASIABIO wishes to announce that the Company had on 26 January 2015 requested for a suspension of trading of its securities for half (1/2) market day, that is, from 9.00 a.m. to 12.30 p.m. on Tuesday, 27 January 2015 pending the release of a material announcement. The request for suspension is made under subparagraph 3.1(b) of Guidance Note 12 of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad. This announcement is dated 26 January 2015.

宝翎

APULA 发表于 26-1-2015 07:14 PM
亞洲生物能源 重大宣佈今停牌
財經26 Jan 2015 23:00
http://www.chinapress.com.my/node/595186

APULA这对0150是好消息还是坏消息呀

icy97

Type	Announcement
Subject	OTHERS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD (“ASIABIO” OR THE “COMPANY”) - HEADS OF AGREEMENT IN RELATION TO THE PROPOSED ACQUISITION OF SEMUA SHIPPING SDN BHD (“SSSB”) AND SEMADO MARITIME SDN BHD (“SMSB”)
The Board of Directors of ASIABIO wishes to announce that the Company has on 27 January 2015 entered into a Heads of Agreement (“HOA”) with Hoe Leong Corporation Ltd. (“HLCL”), Sumatec Resources Berhad (“SRB”) and Reachmont Logistics Sdn Bhd (“RLSB”) (collectively referred to as “Parties”) in relation to a series of transactions which will ultimately facilitate the acquisitions of SSSB and SMSB by Asiabio (“Proposed Transactions”). Pursuant to the HOA, ASIABIO and HLCL, SRB and RLSB have jointly agreed to discuss exclusively in good faith the detailed terms and conditions of the Proposed Transactions with the intention to finalise and enter into a definitive agreement within three (3) months from the date of HOA or such other date as the Parties may mutually agree upon. SSSB was incorporated as an exempt private company on 24 April 1980. It has an authorised share capital of RM1,500,000 comprising 1,500,000 ordinary shares, all of which have been issued and credited as fully paid-up. SMSB was incorporated as a private limited company on 25 November 2000. The authorised share capital of SMSB is RM15,000,000 comprising 15,000,000 ordinary shares, of which 11,400,000 shares have been issued and credited as fully paid-up. SSSB and SMSB are in the business of shipping and provision of shipping-related services. Both SSSB and SMSB, respectively currently owned five (5) and three (3) oil tankers and vessels. SSSB and SMSB are both wholly-owned subsidiaries of Semua International Sdn. Bhd., an associated company of SRB and an investee company of HLCL. The other salient terms of the HOA include that the Parties shall not enter into any discussions or negotiations in any manner whatsoever with any other third party which will adversely affect the Proposed Transactions nor enter into any discussions or negotiations or give access or information to any third party with a view to such discussions or negotiations. A detailed announcement on the Proposed Transactions will be made upon the execution of the Definitive Agreement(s). The HOA may be inspected at the registered office of Asiabio at 10th Floor, Menara Hap Seng, No. 1 & 3 Jalan P. Ramlee, 50250 Kuala Lumpur during normal business hours from Mondays to Fridays (except public holidays) for a period of three (3) months from the date of this announcement. This announcement is dated 27 January 2015.

APULA

Rm0.225........,但Focus.....整大堆等卖

leow8686

但是儿子不会起

APULA

发1.68亿股购2物流公司 亚洲生化进军油气下游业
财经新闻 财经  2015-01-28 08:26
http://www.nanyang.com/node/678011?tid=462

（吉隆坡27日讯）亚洲生化（ASIABIO，0150，创业板）将通过发行总值1.68亿令吉的股票，收购两家油气物流公司，进军油气下游业。

配合收购计划，亚洲生化今天与幸马泰资源（SUMATEC，1201，主板贸服股）、和隆集团（HoeLeong），以及Reachmont物流，签署暂定协议（HOA）。

根据协议，两家油气物流公司Semua船运和Semado海事，将被注入特别用途公司（SPV）。

SPV的股东分别是和隆集团、Reachmont物流，以及Ebony Ritz公司。

亚洲生化将以发行总值1.68亿令吉的股票，收购SPV所有股权。

亚洲生化执行董事陈石义今天在记者会上表示，以收购价粗略估算，发行股票总额将占缴足资本逾20%。

SPV股东将持股逾20%

这意味着，SPV的股东会联合持股超过20%，高于亚洲生化目前的大股东，即香港CPE Growth Capital的11.13%，以及玛拉投资（Pelaburan Mara）的10%。

他指出，1.68亿令吉只是目前暂定价格，非最终收购价，因公司接下来还会进行精密审核程序。

他提到，公司策略是科技育成业者（Technology Incubator）和再生能源，但发现股东难以获得短期回酬。

“我们如今选择（收购）油气相关公司，希望可提供回酬给股东。我们投资的公司，有刚起步和发展中的业务，而我们需要有现在就带来回酬的业务。”

陈石义强调，这两家公司是油气物流公司，运输石油产品，占总供应链成本最高50%，但油价降低会把幅度缩减至最低30%。

“油价下滑，让运输产品的成本变得更廉宜……现在，就是公司要进军油气相关产品的最佳机会。”

2015盈利担保1400万

根据文告，SPV将在2014财年录得800万令吉的净利，预估2015财年增至1400万令吉。

若2015财年盈利无法达标，SPV的股东将支付盈利差异，予亚洲生化。

Reachmont物流董事黄雪华提到，两家油气物流公司有总值约2亿令吉的合约在手，接下来也会继续竞标。

Semua船运和Semado海事为Semua国际独资子公司，后者股东为幸马泰资源及和隆集团。

投资控股仍是主要业务

陈石义表示，油气物流业务只是亚洲生化旗下其中一个业务，投资控股依然会是公司主要业务。

他透露，公司目前减持一些表现欠佳的投资，希望有助于转亏为盈。

截至去年10月杪的第三季，公司录得39万令吉净利，上财年同期则是蒙受190万令吉净亏。

针对绿化科技业务，他称进展顺利，接下来还会继续发展新微生物添加剂（microbial supplement）和木材相关业务。

他也提到，已为燃料生产厂寻获数个伙伴，供应原料制造绿化汽油，但美国系统伙伴需要调整一些程序，加上油价下滑，公司暂时未确定下一步行动。

亚洲生化去年2月与美国Cool Planet能源系统合作，利用科技和生物原料，生产具有高辛烷值的RON105。

亚洲生化执行董事梁国强、和隆集团（Hoe Leong）主席兼总执行长柯毓麟，亦列席今天的记者会。

盘中飙18%

配合最新宣布，该股今天早盘暂停交易，下午2时30分恢复交易后，股价急剧攀升。

闭市时，亚洲生化报21仙，一度飙涨18%，最终起2仙或10.5%，成交量有7216万4000股。【南洋网财经】

icy97

Type	Announcement
Subject	OTHERS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD(“ASIABIO” OR THE “COMPANY”) - CLARIFICATION ON THE NEWS ARTICLE TITLED “ASIABIO MOVES INTO O&G TRANSPORTATION” BY THE BUSINESS TIMES DATED 28 JANUARY 2015
ASIABIO refers to the news article titled “Asiabio moves into O&G transportation” by Business Times on 28 January 2015. ASIABIO, having made due and diligent enquiry with the Board of Directors of the Company, wishes to clarify that the consideration amount of RM168 million, mode of payment for the O&G transport firms, namely Semua Shipping Sdn Bhd (SSSB) and Semado Maritime Sdn Bhd (SMSB), and projected income as reported in the news article are quoted based on the Company’s preliminary indicative valuation and structuring proposal.  The consideration sum and the number of shares to be issued by the Company will nevertheless be subject to further revisions after performing further evaluation, due diligence and negotiation to be concluded between the parties, before culminating into a definitive agreement to be signed following the execution of the Heads of Agreement. As such, the information as provided in the article was not included in the Company’s announcement released on 27 January 2015. The Company will make the appropriate announcement to Bursa Malaysia Securities Berhad (“Bursa Securities”) in a timely manner in accordance with Bursa Securities’ Listing Requirements, should there be any further development on this matter. This announcement is dated 28 January 2015.

icy97

亞洲生物能源進軍油氣運輸業

2015-02-08 10:08      
（吉隆坡7日訊）虧損連連的亞洲生物能源（ASIABIO,0150,創業板貿服組），打算多元化至油氣運輸業。

亞洲生物能源1月30日公佈消息後，股價猛升29%至24.5仙，寫下2009年3月以來最高紀錄，過後卻在2月4日急挫近33%，跌至16.5仙。今年至今，其股價仍升高32%。

外界對於這家生物柴油公司能否順利開展油氣運輸業務，甚至扭轉虧損命運而疑慮四起。

該公司執行董事陳石義接受《The Edge》專訪時說，現在是收購油輪公司的良機，因為經營開銷降低了。

“低油價確實改變了許多事情。展望未來，Semua船運這類公司是不錯的投資對象，畢竟營運成本已經下降了。如果油價衝上100美元，我們就只能望門興嘆了。”

1月27日，該公司宣佈與和隆集團（HLCL）、幸馬泰資源（SUMATEC,1201,主板貿服組）和Reachmont物流有限公司（RLSB）簽署框架合約，優先洽購Semua船運和Semato海事。

根據協議，該公司將發行總值1億6千800萬令吉新股，或佔擴大後繳足資本的20%，用以收購上述資產。

過後，Semua船運和Semato海事的股權將轉到特別用途公司（SPV），而幸馬泰則將特別用途公司的49%股權轉給Reachmont，代價是Reachmont協助幸馬泰減少拖欠的5千600萬令吉債務。（星洲日報／財經‧The Edge專版）

icy97

执行董事减持成小股东 亚洲生化称不知异动原因

财经新闻 财经  2015-02-25 07:46
（吉隆坡24日讯）亚洲生化（ASIABIO，0150，创业板）表示，不知道导致股价异动的原因。

由于该公司近期交投异常热络，因此在今天遭马交所发出不寻常市场交易（UMA）质询。

亚洲生化在答复马交所时指出，该公司没有任何重大企业活动或传言，会导致股价异动，因此，不知道股价异动的原因。

农历新年假期结束后的首日交易，亚洲生化的成交量就比上个交易日大涨640%，达1亿2996万1200股。

针对交投异常热络，马交所今天通过文告，向亚洲生化发出UMA质询。

亚洲生化今天交投持续升温，全天共有2亿854万6600股易手，约占马股总成交量的10%，也成为全场最热门股项，闭市收在12.5仙，全天滑落1.5仙，或10.71%。

梁国强卖2070万股

不过，亚洲生化执行董事梁国强因脱售股权，加上其他股东行使凭单，导致他的股权降低至5%以下，不再是公司大股东。

根据彭博社数据，梁国强是透过Acritaz控股及Platimas私人有限公司，间接持有5.8%和1.3%股权，而本身则直接持有733股。

不过，Acritaz控股在今天脱售2070万股，每股售价13.5仙，而持股权也降低至4.7%，不再是大股东。

在1月底，亚洲生化宣布通过发行总值1.68亿令吉的股票，收购两家油气物流公司，借此进军油气下游业。【南洋网财经】

Notice of Person Ceasing (29C)

ASIA BIOENERGY TECHNOLOGIES BERHAD

Particulars of substantial Securities Holder

Name	Acritaz Holdings Sdn. Bhd.
Address	13A06 Lobby 1 Block A Damansara Intan 1 Jalan SS20/27 47400 Petaling Jaya Selangor
NRIC/Passport No/Company No.	736665-T
Nationality/Country of incorporation	Malaysia
Descriptions (Class & nominal value)	Ordinary Shares of RM0.10 each
Date of cessation	24/02/2015
Name & address of registered holder	Acritaz Holdings Sdn. Bhd. 13A06 Lobby 1 Block A Damansara Intan 1 Jalan SS20/27 47400 Petaling Jaya Selangor
Currency	Malaysian Ringgit (MYR)
Number of securities disposed	20,700,000
Price Transacted ($$)
Circumstances by reason of which a person ceases to be a substantial securities Holder	Disposal of shares and conversion of warrants by other shareholders
Nature of interest	Direct interest
Date of notice	24/02/2015

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD (“ASIABIO” or “the Company”) - ACQUISITION OF SHARES IN NETX HOLDINGS BERHAD
Pursuant to Rule 9.19(26) of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad (“ACE LR”), ASIABIO wishes to announce that Asiabio Capital Sdn. Bhd., a wholly-owned subsidiary of the Company, has since 9 October 2014 cumulatively acquired a total of 6.07% equity in Netx Holdings Berhad (“Netx”), a listed entity on the ACE Market of Bursa Malaysia Securities Berhad (“Investment in the Shares of Netx”). The acquired shares which amounted to 38,000,000 ordinary shares of par value RM0.10 each was acquired from the open market for a total cash consideration sum of RM2,670,000.00. None of the Directors and/or substantial shareholders and/or any person connected to the Directors and/or substantial shareholders of ASIABIO has any interest, either direct or indirect, in the acquisition of shares in Netx. The highest percentage ratio applicable to the Investment in the Shares of Netx pursuant to Rule 10.02(g) of the ACE LR is 4.11% based on the latest audited financial statements of ASIABIO as at 31 January 2014 and Netx, as at 30 June 2014. This announcement is dated 10 March 2015.

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD (“ABT” OR THE “COMPANY”) INVESTMENT AND TRADING OF VARIOUS QUOTED SECURITIES:- ACQUISITION:- • FOCUS DYNAMICS TECHNOLOGIES BERHAD DISPOSAL:- • CARIMIN PETROLEUM BERHAD
The Board of Directors of Asia Bioenergy Technologies Berhad (“ABT” or “the Company”) wishes to announce that its wholly owned subsidiary, Asiabio Capital Sdn Bhd (“ACSB”) that is principally involved in the trading of marketable securities has made acquisition and disposal of the following quoted securities:- Acquisition Focus Dynamics Technologies Berhad (“FOCUS”) Disposal Carimin Petroleum Berhad (“CARIMIN”) Please refer to the attachment for details of the Acquisition and Disposal. This announcement is dated 17 March 2015. http://www.bursamalaysia.com/market/listed-companies/company-announcements/1905825

Attachments ABT Ann Investment (Carimin and Focus) 17 March 2015 (final).pdf

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD (“ABT” OR THE “COMPANY”) - DISPOSAL OF SHARES IN GRAPHENE NANOCHEM PLC (“GN”)
1.            INTRODUCTION The Board of Directors of Asia Bioenergy Technologies Berhad (“ABT” or “the Company”) wishes to announce that its wholly owned subsidiary, Asiabio Capital Sdn Bhd (“ACSB”) that is principally involved in the trading of marketable securities has over the past twelve (12) months disposed off in aggregate 1,160,936 ordinary shares of in Graphene Nanochem Plc (“GN”) for an aggregated sum of RM3.74 million (“GN Consideration”) in cash and in exchange for 416.9409 units of the Bridge Global Growth Fund (“BGGF”) valued at USD416,940.90 or RM1.36 million based on the exchange rate of RM3.262:USD1.00 on 6 October 2014, being the date of the swap (hereinafter referred to as the “Divestment in GN / Investment in BGGF”). 2.         DETAILS OF THE DIVESTMENT IN GN / INVESTMENT IN BGGF 2.1       Information of GN GN is a public listed company listed on the AIM Market of London Stock Exchange. GN is a global nanotechnology company that designs, formulates, manufactures and markets a range of speciality chemicals and advanced materials. Based on the latest audited accounts of GN as at 31 December 2013, its net profit attributable to assets for the year ended and net assets are USD3.67 billion and USD45.89 billion respectively. 2.2       Information on BGGF BGGF is an unquoted fund managed by Bridge Global Absolute Return Fund (“BGARF”), a Segregated Portfolio Company based in the Cayman Islands, whose objective is to deliver an absolute return for investors using a multi-portfolio investment approach. 2.3       Basis of Arriving At the GN Consideration The GN Consideration was derived from the sale of the GN shares in the open market between 17 June 2014 and 2 October 2014 and the exchange of 387,933 GN shares for 416.9409 BGGF units based on the traded price of GN shares on 6 October 2014 of GBP0.6959 or RM3.51 based on the exchange rate of RM5.0438:GBP1.00 on 6 October 2014. 2.4       Utilisation of Proceeds The cash proceeds amounting to RM2.38 million from the Divestment in GN / Investment in BGGF will be channeled back to ABT’s technology incubator funds which will be used for future investments in a three (3) year timeframe. 2.5       Liabilities to be Assumed There are no liabilities, including contingent liabilities and guarantees to be assumed by ABT, arising from the Divestment in GN / Investment in BGGF. 2.6       Original Cost and Date of Investment Part of the GN shares disposed by ACSB was acquired upon the completion of the disposal of 1,143,434 ordinary shares of RM1.00 each in Platinum Nanochem Sdn Bhd (“PNSB”) (representing 1.56% of the equity interest in PNSB) by ABT to Biofutures International Plc (presently known as GN), which was announced by the Company on 26 March 2013, in exchange for 21,018,714 GN shares of 1 pence each that was later consolidated in 1,050,936 GN shares of 20 pence each. The original cost of investment for the PNSB shares held by ABT is RM0.19 million made on 30 June 2012.  The disposal of the PNSB shares for the GN shares resulted in ABT Group realizing a gain on disposal of RM4,463,446 for the financial year ended 31 January 2014. Subsequently further acquisitions of GN shares were made via the open market on 13 September 2014 and 25 September 2014 for a consideration amount of RM0.35 million. 3.         RATIONALE FOR THE DIVESTMENT IN GN / INVESTMENT IN BGGF The Divestment in GN / Investment in BGGF is part of ABT Group’s decision to recoup back its investments in GN, having held that investment since 2013 and reinvestment into the BGGF units that is being managed by BGARF. 4.         RISK FACTORS Save for the normal market and global economic risk, the Board of Directors of ABT is not aware of any other risk factors which may arise as a result of the Divestment in GN / Investment in BGGF. 5.         FINANCIAL EFFECTS The Divestment in GN / Investment in BGGF is not expected to have any material effect on the dividend policy, gearing, share capital and the substantial shareholders’ shareholdings of ABT for the financial year ended 31 January 2015. The Divestment in GN / Investment in BGGF is expected to result in ABT Group recording a loss of RM2.63 million based on the latest book value as adjusted for changes in fair value, for the financial year ended 31 January 2015, which translates to a decrease in earnings per share of approximately 0.003 sen. 6.         APPROVAL REQUIRED The Divestment in GN / Investment in BGGF is not subject to the approval of the shareholders of the Company or any regulatory authorities. 7.         DIRECTORS’ AND SUBSTANTIAL SHAREHOLDERS’ INTEREST None of the Directors and/or substantial shareholders and/or any person connected to the Directors and/or substantial shareholders of ABT has any interest, either direct or indirect in the Divestment in GN / Investment in BGGF. 8.         DIRECTORS’ STATEMENT The Board of Directors of ABT having considered all aspects of the Divestment in GN / Investment in BGGF is of the opinion that it is in the best interest of the ABT Group. 9.         PERCENTAGE RATIO The highest percentage ratio applicable to the Divestment in GN / Investment in BGGF pursuant to Rule 10.02 of the Listing Requirements of Bursa Malaysia Securities Berhad for the ACE Market is 5.76% based on the latest audited financial statements of ABT as at 31 January 2014, adjusting for the completed Rights Issue with Warrants of ABT on 28 April 2014 and GN as at 31 December 2013. This announcement is dated 17 March 2015.

icy97

Change of Financial Year End

ASIA BIOENERGY TECHNOLOGIES BERHAD

Old financial year end	31/01/2015
New financial year end	31/03/2015

Remarks :

The Board of Directors of Asia Bioenergy Technologies Berhad has approved the change of financial year end of the Company from 31 January to 31 March. Thus, the next set of audited financial statements will be made up from 1 February 2014 to 31 March 2015 covering a period of fourteen (14) months. Thereafter, the financial year end of the Company shall end on 31 March for each subsequent year.

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD (“ABT” OR “THE COMPANY”) - DISPOSAL OF SHARES IN GRAPHENE NANOCHEM PLC ("GN")
We refer to the Company’s announcement dated 17 March 2015. The Board of Directors of the Company wishes to clarify the following:- (i) The aggregated disposal sum of RM3.74 million is comprised of a cash proceed of RM2.38 million from the disposal of the GN shares in the open market and a swap for the 416.9409 units of the Bridge Global Growth Fund (“BGGF”) valued at USD416,940.90 or RM1.36 million based on the exchange rate of RM3.262:USD1.00 on 6 October 2014, being the date of the swap. (ii) The Divestment in GN / Investment in BGGF is expected to result in ABT Group recording a loss of RM2.63 million based on the latest book value as adjusted for changes in fair value, which translates to a decrease in earnings per share and net assets per share of approximately 0.003 sen for the financial year ended 31 January 2014, as well as for the financial period ending 31 March 2015, due to the change in the financial year end. This announcement is dated 18 March 2015.

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD (“ABT” OR THE “COMPANY”) INVESTMENT AND TRADING OF VARIOUS QUOTED SECURITIES:- ACQUISITION:- • FOCUS DYNAMICS TECHNOLOGIES BERHAD DISPOSAL:- • CARIMIN PETROLEUM BERHAD
We refer to the Company’s announcement dated 17 March 2015. The Board of Directors of the Company wishes to clarify the following:- (i) The Investment in FOCUS as defined, is not expected to have any material effect on earnings per share and net assets per share, for the financial year ended 31 January 2014, as well as for the financial period ending 31 March 2015, due to the change in the financial year end. (ii) The Divestment in CARIMIN as defined, is expected to result in ABT Group recording an additional loss of RM0.76 million equivalent to a decrease in earnings per share and net assets per share of approximately 0.09 sen, for the financial year ended 31 January 2014, as well as for the financial period ending 31 March 2015, due to the change in the financial year end. This announcement is dated 18 March 2015.

alanyeow

大户终于来了

Secret_agent91

又是相同的手段...
大家小心了～

Semua Shipping 2014 June还亏损RM3m++。 年头Asiabio宣布准备收购Semua Shipping以及Semado Maritime后，Semua shipping年尾的帐目净盈利RM8m.

Semua船運和Semato海事的股權將轉到特別用途公司（SPV），而幸馬泰則將特別用途公司的49%股權轉給Reachmont，代價是Reachmont協助幸馬泰減少拖欠的5千600萬令吉債務。（星洲日報／財經‧The Edge專版）

Reachmont的股东Bong Siet Fatt其实原本就是Semua的GM。

原因是Semua Shipping与Semado Maritime的持有大股东，也就是Hoe Leong Corporation在帐目上做了adjustment让Semua Shipping从亏损变成赚钱。

Hoe Leong Corporation 也是 Ebony Ritz Sdn Bhd 的大股东，持有80% Ebony Ritz。

Secret_agent91

Semua Shipping原本都是亏损的，大股东Hoe Leong Corporation就算损失SGD3.9m interest & admin fee都要卖掉Semua shipping，让Semua Shipping在大众眼里看来是赚钱的公司。

这一切Asiabio的director Steve Tan都已经是知道了的。如果Asiabio坚持收购，就像回之前的炒作。

大众的血汗钱，要小心了。鲨鱼出现～

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31/01/2015

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/01/2015	31/01/2014	31/01/2015	31/01/2014
		$$'000	$$'000	$$'000	$$'000

1	Revenue	15,239	2,266	51,341	3,700
2	Profit/(loss) before tax	-5,048	267	-6,359	-709
3	Profit/(loss) for the period	-5,048	267	-6,359	-710
4	Profit/(loss) attributable to ordinary equity holders of the parent	-4,558	269	-6,230	-645
5	Basic earnings/(loss) per share (Subunit)	-0.43	0.07	-0.59	-0.16
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0709		0.0559